
Apr
Industry 4.0 Masterclass



Leading authority on strategy and competitiveness
Henrik is named by Financial Times as one of the leading authority on strategy and competitiveness. One of the most influential business thinkers, who has set the agenda for nations and the fortune 100 companies.
He is notorious for his personal involvement to define the core differentiating, competitive aspects and to identify how to innovate and where to transform.
Originator of the Industry 4.0 and Digital themes today
Henrik is best known as the originator of the “4th Industrial Revolution” (Industry 4.0) and the mastermind of the European Digital Revolution (German Digital Agenda), which ignited the global themes of today. As the inaugurator of Germany’s digital agenda in 09, he ignited a global wave of national and corporate digital strategy adoptions.
Henrik Works with 23% of the Fortune 500 companies and multiple government entities
MEDIA PARTNERS

Feb
Industry 4.0 Masterclass



Leading authority on strategy and competitiveness
Henrik is named by Financial Times as one of the leading authority on strategy and competitiveness. One of the most influential business thinkers, who has set the agenda for nations and the fortune 100 companies.
He is notorious for his personal involvement to define the core differentiating, competitive aspects and to identify how to innovate and where to transform.
Originator of the Industry 4.0 and Digital themes today
Henrik is best known as the originator of the “4th Industrial Revolution” (Industry 4.0) and the mastermind of the European Digital Revolution (German Digital Agenda), which ignited the global themes of today. As the inaugurator of Germany’s digital agenda in 09, he ignited a global wave of national and corporate digital strategy adoptions.
Henrik Works with 23% of the Fortune 500 companies and multiple government entities
MEDIA PARTNERS

May
2ND ANNUAL CDx & PERSONALIZED MEDICINE SUMMIT
2ND ANNUAL CDx & PERSONALIZED MEDICINE SUMMIT
The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices within the companion diagnostics (CDx) industry. More importantly, partnership opportunities and commercializing CDx tests with pharmaceutical and biotech companies will be explored.
KEY TOPICS
WHY YOU SHOULD BE THERE ?
- Novel Diagnostic Technologies
- Strategic Partnerships for CDx – Challenges and Opportunities
- Partnering strategies to achieve successful commercialization of CDx
- Future key areas for the Development of Personalized Medicine
- Partnering to Deliver Personalized Medicine
- Finding the appropriate business models for CDx companies
- Development of new Business Models for the Healthcare Industry
- The role of complementary diagnostics in targeted therapy selection
- Regulatory Update on Companion Diagnostics
- Emerging investment trends and opportunities
- Regulatory and Commercial Considerations
2. Learn about the latest technologies and most pressing topics specific to your business.
3. Discuss about new opportunities for your products and services with key decision makers.
4. Get new tips, tactics and implement the latest innovations.
5. Get an overview on innovative emerging technologies and business partnership opportunities.
6. Interact and connect with leading companies and their representatives.
MEDIA PARTNERS
REQUEST FORM

Nov
2nd Annual Cancer Immunotherapy Summit
2ND ANNUAL CANCER IMMUNOTHERAPY SUMMIT
KEY TOPICS
WHY YOU SHOULD BE HERE?
FEATURED SPEAKERS
FEATURED COMPANIES
MEDIA PARTNERS
REQUEST FORM

Feb
INTERNATIONAL BIOSIMILARS SUMMIT
INTERNATIONAL BIOSIMILARS SUMMIT
KEY TOPICS
WHY YOU SHOULD BE HERE?
FEATURED SPEAKERS
FEATURED COMPANIES
SPONSOR
MEDIA PARTNERS
REQUEST FORM

Feb
GLOBAL CDx & PERSONALIZED MEDICINE SUMMIT
GLOBAL CDx & PERSONALIZED MEDICINE SUMMIT
Personalized medicine will change the way medicine is practiced. The new therapies will benefit both patients and physicians in many ways. Patients will experience fewer side effects and physicians will be armed with more precise tools and medicine. Companion diagnostic co-development has the potential to significantly alter the drug development process and commercialization of drug candidates by yielding safer drugs with enhanced therapeutic efficacy in a faster, more cost-effective manner. This premier B2B summit will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in the CDx.
The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices within the companion diagnostics (CDx) industry. More importantly, partnership opportunities and commercializing CDx tests with pharmaceutical and biotech companies will be explored.
KEY TOPICS
WHY YOU SHOULD BE THERE ?
- Novel Diagnostic Technologies
- Strategic Partnerships for CDx – Challenges and Opportunities
- Partnering strategies to achieve successful commercialization of CDx
- Implementation of a Personalized Medicine program
- Emerging approach to precision medicine strategy
- Partnering to Deliver Personalized Medicine
- Finding the appropriate business models for CDx companies
- The role of complementary diagnostics in targeted therapy selection
- The laboratory developed test (LDT) & In vitro diagnostic (IVD) Models
- Liquid biopsy methodologies for non-invasive diagnostic development
- Next generation sequencing protocols
- Regulatory Update on Companion Diagnostics
2. Learn about the latest technologies and most pressing topics specific to your business.
3. Discuss about new opportunities for your products and services with key decision makers.
4. Get new tips, tactics and implement the latest innovations.
5. Get an overview on innovative emerging technologies and business partnership opportunities.
6. Interact and connect with leading companies and their representatives.
FEATURED SPEAKERS
SPONSORS
FEATURED COMPANIES
MEDIA PARTNERS
REQUEST FORM

Feb